Development asset linked to Children's Hospital Zhejiang in public FDA and regional records.
pharma · BPD - Bronchopulmonary Dysplasia
Children's Hospital Zhejiang
The Children's Hospital of Zhejiang University School of Medicine
Children's Hospital Zhejiang drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
109 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 109
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Children's Hospital Zhejiang pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Children's Hospital Zhejiang drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Children's Hospital Zhejiang in public FDA and regional records.